Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-15

Clinical Trial Update: Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension. [Phase 4]

View source ↗

Summary

A Phase 4 study comparing the efficacy and safety of the valsartan/hydrochlorothiazide combination versus valsartan or hydrochlorothiazide monotherapy in elderl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • VALSARTAN (Valsartan)
  • Valsartan/Hydrochlorothiazide (Valsartan and Hydrochlorothiazide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2010-12-15